RAPT Therapeutics (RAPT) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.86
-0.79
-0.73
-0.66

Details

Expected EPS
-0.809297
Actual EPS
-0.79
Surprise EPS
0.02
Surprise Percent
+2.38%

Description

RAPT Therapeutics (RAPT) has reported earnings of -0.79 per share for Q2 2024.

0 Comments

Share your thoughts